L. Sakr

发表

Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group

M. Hudson, M. Baron, L. Sakr, 2018, Journal of scleroderma and related disorders.

Phenotypic Heterogeneity of Potentially Curable Non–Small-Cell Lung Cancer: Cohort Study with Cluster Analysis

S. Suissa, L. Sakr, P. Ernst, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cytology-based treatment decision in primary lung cancer: is it accurate enough?

L. Sakr, F. Barlesi, A. Loundou, 2012, Lung cancer.

Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma

L. Sakr, G. Tassi, V. Pinelli, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

F. Maldonado, L. Sakr, A. Loundou, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The use of a standardized Chinese herbal formula in patients with advanced lung cancer: a feasibility study.

L. Sakr, G. Kasymjanova, J. Agulnik, 2018, Journal of integrative medicine.

The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

L. Sakr, E. Ulsperger, G. Baumgartner, 1998, Cancer letters.

The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma.

L. Sakr, P. Fiset, A. Spatz, 2019, Lung cancer.

Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer

L. Sakr, P. Fiset, L. V. van Kempen, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Tracheal Glomus Tumor: A Multidisciplinary Approach to Management

L. Sakr, C. Doddoli, H. Dutau, 2011, Respiratory Care.

Sarcoid-like Reaction Discovered on EBUS-TBNA of Intrathoracic Lymph Nodes During Immunotherapy for Metastatic Melanoma

L. Sakr, Hangjun Wang, M. Frohlich, 2019, Journal of immunotherapy.

Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.

L. Sakr, G. Kasymjanova, J. Agulnik, 2020, Current oncology.

Bronchoscopy during the COVID-19 pandemic: A Canadian Thoracic Society Position Statement update

Elaine Dumoulin, L. Sakr, G. Bendiak, 2022 .

Massive Hemoptysis: An Update on the Role of Bronchoscopy in Diagnosis and Management

L. Sakr, H. Dutau, 2010, Respiration.

A retrospective study of silicone stent placement for management of anastomotic airway complications in lung transplant recipients: short- and long-term outcomes.

L. Sakr, M. Reynaud‐Gaubert, S. Boniface, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

L. Sakr, K. Filion, J. Udell, 2018, British Medical Journal.

Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.

G. Batist, L. Sakr, W. Sateren, 2017, Current oncology.

P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC with High PD-L1 Expression Tested on Cytology Versus Biopsy Samples

L. Sakr, A. Spatz, G. Kasymjanova, 2018, Journal of Thoracic Oncology.

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

L. Sakr, A. Papadakis, Hangjun Wang, 2022, Current oncology.

Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec

L. Sakr, G. Kasymjanova, J. Agulnik, 2021, Current oncology.

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

K. Sultanem, L. Sakr, G. Kasymjanova, 2021, Current oncology.

Use of a Tunnelled Pleural Catheter for the Management of Refractory Hepatic Hydrothorax: A New Therapeutic Option

J. Sahel, L. Sakr, H. Dutau, 2010, Respiration.

Bronchoscopy during the COVID-19 pandemic: A Canadian Thoracic Society position statement

Elaine Dumoulin, Christopher A. Hergott, L. Sakr, 2021, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?

L. Sakr, T. Muanza, G. Kasymjanova, 2018, Current oncology.

Understanding Clinical Practice and Survival Outcomes in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer in a Single Centre in Quebec.

L. Sakr, G. Kasymjanova, J. Agulnik, 2020, Current Oncology.

Phenotypic Heterogeneity of Potentially Curable Non–Small-Cell Lung Cancer: Cohort Study with Cluster Analysis

S. Suissa, L. Sakr, P. Ernst, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Thoracoscopic Assessment of Pleural Tumor Burden in Patients with Malignant Pleural Effusion: Prognostic and Therapeutic Implications

F. Maldonado, L. Sakr, A. Loundou, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.